The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and Prevention Studies (SEPSIS). This pioneering center of excellence is dedicated to advancing understanding, prevention, and management of sepsis, a life-threatening condition caused by a dysregulated immune response to infection. The SEPSIS Center will be led by … Read more
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days after their stroke than those receiving standard clot removal, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025. … Read more
The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025. The conference, in Los Angeles, Feb. 5-7, 2025, is a world premier meeting for researchers and … Read more
A young wheelchair-user who has been without power for close to two weeks has said she feels “forgotten about” and is “losing hope”. Emma Ward (22), from Athenry, Co Galway, has been without electricity since late on Thursday, January 23rd, as Storm Éowyn braced the country. Ms Ward was born with scoliosis and has hurler … Read more
The Future of Player Contracts: A Balancing Act Between Performance and Well-being Table of Contents The Future of Player Contracts: A Balancing Act Between Performance and Well-being Performance-Based Contracts: Rewarding Excellence The Fatigue Factor: A Growing Concern Navigating the Future: A Delicate Balance The recent contract negotiations of Yunus Akgün with Galatasaray have shone a … Read more
Archyde For millions of women, menopause isn’t just about hot flashes or mood swings—it can also signal the beginning of a painful journey with osteoarthritis (OA). This degenerative joint condition,which disproportionately affects postmenopausal women,leads to chronic pain,stiffness,and a important decline in quality of life. While hormonal changes during menopause have long been linked to OA, … Read more
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular disease remains a leading cause of death and disability worldwide. Heart failure (HF) is the end stage of various cardiovascular diseases. Despite recent advancements in understanding of HF pathogenesis and treatment, the prognosis of patients with HF remains poor. Inflammation is a key … Read more
In recent years, low-level electrical stimulation has emerged as an effective rehabilitative tool for people with spinal cord injuries. But not all patients have benefited because researchers often exclude people from studies if they have involuntary muscle spasms, known as spasticity. In a new study in Science Translational Medicine, researchers in Europe say they have … Read more
A Promising New Target for Treating Lissencephaly: A Molecular Breakthrough Lissencephaly, a rare and devastating group of genetic disorders, affects brain development, causing a lack of normal folds and leading to seizures and intellectual disability. Sadly, there are currently no effective treatments available. However, a groundbreaking new study from Yale University offers a glimmer of … Read more